TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Premeon Pharma Oy
Closing information (x1000 DKK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
1,873
|
15
|
30 |
Financial expenses | 0 | ||
Earnings before taxes |
-7
|
104
|
0 |
Total assets |
3,152
|
418
|
52 |
Current assets |
483
|
224
|
45 |
Current liabilities |
3,041
|
291
|
30 |
Equity capital |
119
|
127
|
22 |
- share capital |
22
![]() |
22
![]() |
22 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
3.8%
|
30.4%
|
42.3% |
Turnover per employee |
1,873
|
15
|
30 |
Profit as a percentage of turnover |
-0.4%
|
693.3%
|
0% |
Return on assets (ROA) | 24.9% | ||
Current ratio |
15.9%
|
77.0%
|
150.0% |
Return on equity (ROE) |
-5.9%
|
81.9%
|
0% |
Change turnover |
1,859
|
-15 | |
Change turnover % |
12500%
|
-50% | |
Chg. No. of employees |
0
![]() |
0 | |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.